Once again sharing their generosity with Mass General, John R. Gallagher III and Katherine A. Gallagher have created an endowed chair in clinical nephrology.

A couple dedicated to improving the lives of others has once again shared their generosity with the Massachusetts General Hospital community by creating the John R. Gallagher III and Katherine A. Gallagher Endowed Chair in Clinical Nephrology. This is not the first time these longtime supporters and friends of the hospital have extended their support for research and clinical care. In 2012, they also established the John R. Gallagher III and Katherine A. Gallagher Endowed Chair in Gastrointestinal Cancer Research.

“We are very thankful to the Gallaghers for their amazing support over the years,” says Peter L. Slavin, MD, MGH president.

“We are very thankful to the Gallaghers for their amazing support over the years,” says Peter L. Slavin, MD, MGH president. “Not only are John and Katherine amazing supporters and philanthropists, they also are truly wonderful people that I am honored to call friends.”

Known to Many

The Gallaghers are known to many in the MGH community and they also were honored in 2011 at the one hundred gala, the Mass General Cancer Center’s annual event recognizing “Everyday Amazing” individuals who are committed to the fight against cancer. Katherine Gallagher also recently endowed the Katherine A. Gallagher Integrative Therapies Program, which focuses on improving the quality of life and well-being of patients with cancer and their families and friends through free wellness services plus education and support workshops.

In June 2015, Leslie S. T. Fang, MD, PhD, of the Division of Nephrology, was honored as the inaugural incumbent of the endowed position in clinical nephrology, while Nabeel M. Bardeesy, PhD, previously was named to the gastrointestinal cancer research chair.

“I am eternally grateful that John R. Gallagher III and Katherine Gallagher decided to recognize clinical activities as they pertain to the day-to-day care of patients,” says Dr. Fang. “While clinical activities do not engender earth-shattering discoveries of scientific import, these activities form the backbone upon which all of our other endeavors would be judged. It is my honor to be the incumbent of this esteemed chair and I hope that this position would allow for continuing embracement of clinical excellence.”

This story first appeared in MGH Hotline.